top of page

DEANNA MORALES

RHABDOMYOSARCOMA JOURNEY

My Sarcoma Journey

This video was released in November 2024, following 19 months of intensive treatment, which included numerous surgeries and aggressive chemotherapy.  Just as Deanna made the decision to share her story, she received the devastating news that the cancer had returned.

Go Fund Me

Your kindness and generosity are deeply appreciated. As her family and friends, we are incredibly thankful for your support as you join Deanna in her battle to overcome this rare disease once again.

thumbnail_image0.jpg

What is Sclerosis Rhabdomyosarcoma

It’s a rare subtype of rhabdomyosarcoma (RMS), a cancer originating in muscle tissue. 

 

Sclerosing rhabdomyosarcoma (SRMS) is an exceedingly rare variant of rhabdomyosarcoma, with fewer than 50 documented cases reported in the English-language literature to date...

and Deanna Morales is one of them.

 

Rhabdomyosarcoma is a soft tissue sarcoma that forms from muscle cells, and is a rare cancer affecting the connective tissues, including muscles, bones, nerves, cartilage, and blood vessels.

Rhabdomyosarcoma itself is already rare, accounting for about 1% of all adult cancer cases.

 

Within that, sclerosing rhabdomyosarcoma is even rarer, making up only a tiny fraction of RMS cases.  Because of its rarity, there is limited data on how many adult cancer cases are attributed to sclerosing RMS, making it even more challenging to find effective treatment options. Since Deanna’s recurrence in November 2024, she has traveled across the country in search of solutions, consulting with medical experts to explore potential treatments for this aggressive and rare disease. 

"Sending love and prayers to you Deanna ❤️ you are such a beautiful courageous soul. God is good 🙏🏼 your story will help and encourage others"

"You are brave you are inspiring us who fight battles sending prayers love healing 🙏🏼🙏🏼🙏🏼"

Upcoming Event Fundraisers

Please Feel Free To Share Any Information and Resources That Could Help


bottom of page